Fierce Health Technology October 13, 2020
Paige Minemyer

As the coronavirus pandemic hit U.S. shores, CVS Health was in the midst of a major business transformation following its acquisition of Aetna.

CVS closed its $69 billion acquisition of Aetna—one of the largest payers in the country—in late 2018 and was 20 months into integrating when it had to adapt to COVID-19, CEO Larry Merlo said.

Rather than creating a hurdle, Merlo said the pandemic served to underscore CVS’ key strategic goal of making healthcare easier to access through the combined power of its suite of health plans, pharmacy benefit management tools and retail pharmacies.

“The pandemic really became an opportunity to reprioritize elements of that transformation journey,” Merlo said. “It really brought our strategy to life in a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Healthcare System, Insurance, Payer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Retail care, Trends
Private equity firm to buy Walgreens for $10B, report says
As Tariffs Begin, What Will They Do To Drug Prices And Availability?
Podcast: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe
Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth
Why Walgreens Specialty Pharmacy May Be Its Most Desirable Asset

Share This Article